The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Novartis Ireland Limited .

Filed returns
7
match these filters
Matching filed returns per period 0 0 1 1 2 May–Aug 2016: 1 filed returns Sep–Dec 2016: 1 filed returns Jan–Apr 2018: 1 filed returns Sep–Dec 2019: 1 filed returns May–Aug 2020: 1 filed returns Sep–Dec 2020: 2 filed returns 2018
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2020 Novartis Ireland Limited Health Expansion of Newborn Screening (Legislation) 2 On lobbying.ie
Sep–Dec 2020 Novartis Ireland Limited Health Timely access to innovative new products, IP, EU Pharma Strategy (Legislation) 1 On lobbying.ie
May–Aug 2020 Novartis Ireland Limited Health Supporting intellectual property incentives in rare diseases, funding for new medicines, EU Pharmaceutical Strategy, (Legislation) 1 On lobbying.ie
Sep–Dec 2019 Novartis Ireland Limited Health Reimbursement of new Medicines, Intellectual Property, need for new approaches in cell & gene therapy (Matters involving public funds) 4 On lobbying.ie
Jan–Apr 2018 Novartis Ireland Limited Health Strong Intellectual Property protection is a critical pre-requisite to maintaining an environment where innovation can thrive in healthcare (Legislation) 1 On lobbying.ie
Sep–Dec 2016 Novartis Ireland Limited Health Making Heart Failure a public policy priority (Public policy or programme) 2 On lobbying.ie
May–Aug 2016 Novartis Ireland Limited Health Make heart failure (HF) a health policy priority - update on initiatives taking place in the West (Public policy or programme) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 7 100.0%